RHHBY Financials 07/16/2014 10:06:03
Roche Holding Ltd
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 54,660,000 51,832,000 47,175,000 52,749,000
Cost of Revenue 13,435,000 13,301,000 12,771,000 14,261,000
Gross Profit 41,226,000 38,531,000 34,404,000 38,487,000
Operating Expenses
Research and Development 10,423,000 10,435,000 8,904,000 10,756,000
Sales, General and Admin. 12,389,000 12,664,000 11,112,000 13,263,000
Non-Recurring Items - - - -
Other - - - -
Operating Income 18,413,000 15,431,000 14,388,000 14,468,000
Income From Continuing Operations
Add'l Income/Expense Items (134,000) (47,000) 692,000 598,000
Earnings Before Interest and Tax 18,280,000 15,384,000 15,093,000 15,063,000
Interest Expense 1,777,000 2,101,000 2,383,000 3,035,000
Earnings Before Tax 16,503,000 13,283,000 12,710,000 12,028,000
Income Tax 3,715,000 2,730,000 2,503,000 2,489,000
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - 13,000 (3,000)
Net Income Cont. Operations 12,788,000 10,553,000 10,219,000 9,535,000
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 12,788,000 10,553,000 10,206,000 9,539,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 12,788,000 10,553,000 10,206,000 9,539,000